Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale
- PMID: 22003937
- DOI: 10.1111/j.1529-8027.2011.00351.x
Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale
Abstract
The assessment of chemotherapy-induced peripheral neurotoxicity (CIPN) is still uncertain as several of the most frequently used scales do not rely on a formal neurological evaluation and depend on patients' reports and examiners' interpretations. The aim of this study was to compare the assessment of CIPN using the National Cancer Institute Common Toxicity Criteria (NCI-CTC) scale and a formal neurological assessment scored with the Total Neuropathy Score (TNS, i.e., a composite scale designed to grade the impairment in neuropathy patients) to identify possible discrepancies in the diagnosis. In this prospective study, 155 patients treated with cisplatin/carboplatin or with paclitaxel/docetaxel and CIPN were examined in a collaborative oncological/neurological multi-center trial using the NCI-CTC scale and the TNS; the results were then extensively compared. We evidenced that the TNS allows possible misdiagnosed neuropathies to be revealed. In fact, the NCI-CTC evaluation performed by experienced examiners overestimated the occurrence of motor neuropathy, possibly because of the presence of confounding factors (e.g., fatigue, depression, cachexia), which might be difficult to be ruled out without a formal neurological examination. This study strongly indicates that a more formal neurological assessment of patients with CIPN than that achievable with the common toxicity scales (e.g., NCI-CTC) is advisable.
© 2011 Peripheral Nerve Society.
Similar articles
-
Multi-center assessment of the Total Neuropathy Score for chemotherapy-induced peripheral neurotoxicity.J Peripher Nerv Syst. 2006 Jun;11(2):135-41. doi: 10.1111/j.1085-9489.2006.00078.x. J Peripher Nerv Syst. 2006. PMID: 16787511
-
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale.J Peripher Nerv Syst. 2007 Sep;12(3):210-5. doi: 10.1111/j.1529-8027.2007.00141.x. J Peripher Nerv Syst. 2007. PMID: 17868248
-
Oxaliplatin scale and National Cancer Institute-Common Toxicity Criteria in the assessment of chemotherapy-induced peripheral neuropathy.Anticancer Res. 2011 Oct;31(10):3493-6. Anticancer Res. 2011. PMID: 21965767
-
Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools.Eur J Cancer. 2010 Feb;46(3):479-94. doi: 10.1016/j.ejca.2009.12.008. Epub 2010 Jan 4. Eur J Cancer. 2010. PMID: 20045310 Review.
-
The total neuropathy score: a tool for measuring chemotherapy-induced peripheral neuropathy.Oncol Nurs Forum. 2008 Jan;35(1):96-102. doi: 10.1188/08.ONF.96-102. Oncol Nurs Forum. 2008. PMID: 18192158 Review.
Cited by
-
Efficacy and tolerability of controlled-release oxycodone for oxaliplatin-induced peripheral neuropathy and the extension of FOLFOX therapy in advanced colorectal cancer patients.Support Care Cancer. 2014 Jun;22(6):1579-84. doi: 10.1007/s00520-014-2132-4. Epub 2014 Jan 24. Support Care Cancer. 2014. PMID: 24452412 Free PMC article.
-
Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data.Cancer Nurs. 2019 May/Jun;42(3):179-189. doi: 10.1097/NCC.0000000000000596. Cancer Nurs. 2019. PMID: 29649081 Free PMC article.
-
Approaches to measure paediatric chemotherapy-induced peripheral neurotoxicity: a systematic review.Lancet Haematol. 2020 May;7(5):e408-e417. doi: 10.1016/S2352-3026(20)30064-8. Lancet Haematol. 2020. PMID: 32359452 Free PMC article.
-
Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.JAMA. 2013 Apr 3;309(13):1359-67. doi: 10.1001/jama.2013.2813. JAMA. 2013. PMID: 23549581 Free PMC article. Clinical Trial.
-
Patterns of chemotherapy-induced toxicities and outcome in children and adolescents with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.Pediatr Blood Cancer. 2017 Sep;64(9):10.1002/pbc.26479. doi: 10.1002/pbc.26479. Epub 2017 Mar 23. Pediatr Blood Cancer. 2017. PMID: 28333415 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical